Top

Sports Medicine

Published in:

01-12-2004 | Leading Article

Lipid-Induced Insulin Resistance in the Liver

Role of Exercise

Author: Dr Christos S. Katsanos

Published in: Sports Medicine | Issue 14/2004

Abstract

Hepatic lipid accumulation may be a result of one or several of the following factors: increased delivery of adipose tissue or dietary fatty acids to the liver, increased de novo synthesis of fatty acids in the liver, decreased rate of hepatic fatty-acid oxidation, or decreased rate in the exit of fatty acids from the liver in the form of triglycerides. Delivery of fatty acids to the liver appears to be the most potent mechanism for hepatic lipid accumulation. Hepatic lipid accumulation is linked to the development of hepatic insulin resistance, which is demonstrated by the impaired suppression of hepatic glucose output by insulin. Current evidence suggests that defects associated with the molecular mechanisms responsible for the propagation of the insulin signal in the liver cells are responsible for the impaired insulin effect and that these defects can develop secondary to lipid accumulation in the liver. Hepatic lipid accumulation appears to affect the activity of phosphatidylinositol 3-kinase, which has a central role in mediating the insulin action in hepatocytes. Generally, exercise has been shown to enhance the insulin action in the liver. Although an exercise-related mechanistic link between attenuation in hepatic lipid accumulation and enhancement in insulin action in the liver has not been described yet, the benefits of exercise on hepatic insulin action may relate to the potential effects of exercise on regulating/preventing hepatic lipid accumulation. However, direct effects of exercise on insulin action in the liver, independent of any effects on hepatic lipid metabolism, cannot currently be excluded. Further research is needed to evaluate the relative importance of exercise in the treatment of hepatic insulin resistance, specifically as it relates to lipid accumulation in the liver.

Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995; 75: 473–86PubMed

Kim JK, Fillmore JJ, Chen Y, et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A 2001; 98: 7522–7PubMedCrossRef

Taghibiglou C, Rashid-Kolvear F, Van Iderstine SC, et al. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and over-expression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem 2002; 277: 793–803PubMedCrossRef

Carpentier A, Taghibiglou C, Leung N, et al. Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J Biol Chem 2002; 277: 28795–802PubMedCrossRef

Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844–50PubMedCrossRef

Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87: 3023–8PubMedCrossRef

Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002; 109: 1345–50PubMed

Kraegen EW, Clark PW, Jenkins AB, et al. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991; 40: 1397–403PubMedCrossRef

Fisher SJ, Kahn CR. Insulin signaling is required for insulin’s direct and indirect action on hepatic glucose production. J Clin Invest 2003; 111: 463–8PubMed

10.

Zammit VA, Waterman IJ, Topping D, et al. Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 2001; 131: 2074–7PubMed

11.

Michael MD, Kulkarni RN, Postic C, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000; 6: 87–97PubMed

12.

Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414: 799–806PubMedCrossRef

13.

Whitehead JP, Clark SF, Urso B, et al. Signalling through the insulin receptor. Curr Opin Cell Biol 2000; 12: 222–8PubMedCrossRef

14.

Previs SF, Withers DJ, Ren JM, et al. Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem 2000; 275: 38990–4PubMedCrossRef

15.

Sutherland C, O’Brien RM, Granner DK. New connections in the regulation of PEPCK gene expression by insulin. Philos Trans R Soc Lond B Biol Sci 1996; 351: 191–9PubMedCrossRef

16.

Bevan P. Insulin signalling. J Cell Sci 2001; 114: 1429–30PubMed

17.

Ma Y, Wang P, Kuebler JF, et al. Hemorrhage induces the rapid development of hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol 2003; 284: G107–15PubMed

18.

Gu S, Langlais P, Liu F, et al. mNAT3, an N-system amino acid transporter expressed in hepatocytes and regulated by an insulin-activated and PI3 dinase-dependent signaling. Biochem J 2003; 371 (Pt 3): 721–31PubMedCrossRef

19.

Wahren J, Sato Y, Ostman J, et al. Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise. J Clin Invest 1984; 73: 1367–76PubMedCrossRef

20.

Murray RK, Granner DK, Mayes PA, et al. Harper’s Biochemistry. 24th ed. Stanford (CT): Appleton & Lange, 1996

21.

Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183–92PubMedCrossRef

22.

Lam TK, Carpentier A, Lewis GF, et al. Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am J Physiol Endocrinol Metab 2003; 284: E863–73PubMed

23.

Wiggins D, Gibbons GF. The lipolysis/esterification cycle of hepatic triacylglycerol: its role in the secretion of very-low-density lipoprotein and its response to hormones and sulphonylureas. Biochem J 1992; 284 (Pt 2): 457–62PubMed

24.

de Almeida IT, Cortez-Pinto H, Fidalgo G, et al. Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clin Nutr 2002; 21: 219–23PubMedCrossRef

25.

Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106: 171–6PubMedCrossRef

26.

Gavrilova O, Marcus-Samuels B, Graham D, et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000; 105: 271–8PubMedCrossRef

27.

Coppack SW, Evans RD, Fisher RM, et al. Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 1992; 41: 264–72PubMedCrossRef

28.

Abbasi F, McLaughlin T, Lamendola C, et al. Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance. Metabolism 2000; 49: 151–4PubMedCrossRef

29.

Frayn KN. Visceral fat and insulin resistance: causative or correlative? Br J Nutr 2000; 83Suppl. 1: S71–7PubMed

30.

Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994; 74: 761–811PubMed

31.

Conway JM, Chanetsa FF, Wang P. Intraabdominal adipose tissue and anthropometric surrogates in African American women with upper- and lower-body obesity. Am J Clin Nutr 1997; 66: 1345–51PubMed

32.

Rebuffe-Scrive M, Anderson B, Olbe L, et al. Metabolism of adipose tissue in intraabdominal depots in severely obese men and women. Metabolism 1990; 39: 1021–5PubMedCrossRef

33.

Nguyen-Duy TB, Nichaman MZ, Church TS, et al. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab 2003; 284(6): E1065–71PubMed

34.

Mittelman SD, Van Citters GW, Kirkman EL, et al. Extreme insulin resistance of the central adipose depot in vivo. Diabetes 2002; 51: 755–61PubMedCrossRef

35.

Arner P. Catecholamine-induced lipolysis in obesity. Int J Obes Relat Metab Disord 1999; 23Suppl. 1: 10–3PubMedCrossRef

36.

Wiesenthal SR, Sandhu H, McCall RH, et al. Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 1999; 48: 766–74PubMedCrossRef

37.

Volpe JJ, Vagelos PR. Mechanisms and regulation of biosynthesis of saturated fatty acids. Physiol Rev 1976; 56: 339–417PubMed

38.

Griffiths MA, Baker DH, Yu XX, et al. Effects of acute exercise on hepatic lipogenic enzymes in fasted and refed rats. J Appl Physiol 1995; 79: 879–85PubMed

39.

Aarsland A, Chinkes D, Wolfe RR. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J Clin Invest 1996; 98: 2008–17PubMedCrossRef

40.

Shimomura I, Matsuda M, Hammer RE, et al. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 2000; 6: 77–86PubMed

41.

Schwarz JM, Linfoot P, Dare D, et al. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, lowcarbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 2003; 77: 43–50PubMed

42.

Gauthier MS, Couturier K, Latour JG, et al. Concurrent exercise prevents highfat-diet-induced macrovesicular hepatic steatosis. J Appl Physiol 2003; 94: 2127–34PubMed

43.

Terao T, Fujise T, Yamashita Y, et al. Dependence of lipid-lipoprotein metabolism on exercise intensity in experimental fatty liver rats. Tokai J Exp Clin Med 1988; 13: 99–107PubMed

44.

Pagliassotti MJ, Prach PA, Koppenhafer TA, et al. Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats. Am J Physiol 1996; 271: R1319–26PubMed

45.

Pagliassotti MJ, Kang J, Thresher JS, et al. Elevated basal PI 3-kinase activity and reduced insulin signaling in sucrose-induced hepatic insulin resistance. Am J Physiol Endocrinol Metab 2002; 282: E170–6PubMed

46.

Mittelman SD, Fu YY, Rebrin K, et al. Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J Clin Invest 1997; 100: 3121–30PubMedCrossRef

47.

Ader M, Bergman RN. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol 1990; 258: E1020–32PubMed

48.

Lewis GF, Vranic M, Harley P, et al. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes 1997; 46: 1111–9PubMedCrossRef

49.

Boden G. Interaction between free fatty acids and glucose metabolism. Curr Opin Clin Nutr Metab Care 2002; 5: 545–9PubMedCrossRef

50.

McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51: 7–18PubMedCrossRef

51.

Sidossis LS, Mittendorfer B, Walser E, et al. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am J Physiol 1998; 275: E798–805PubMed

52.

Prip-Buus C, Perdereau D, Foufelle F, et al. Induction of fattyacid-synthase gene expression by glucose in primary culture of rat hepatocytes: dependency upon glucokinase activity. Eur J Biochem 1995; 230: 309–15PubMedCrossRef

53.

Shiota M, Postic C, Fujimoto Y, et al. Glucokinase gene locus transgenic mice are resistant to the development of obesity-induced type 2 diabetes. Diabetes 2001; 50: 622–9PubMedCrossRef

54.

Ferre T, Riu E, Franckhauser S, et al. Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance. Diabetologia 2003; 46: 1662–8PubMedCrossRef

55.

Lam TK, van de Werve G, Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab 2003; 284: E281–90PubMed

56.

Tippett PS, Neet KE. Specific inhibition of glucokinase by long chain acyl coenzymes A below the critical micelle concentration. J Biol Chem 1982; 257: 12839–45PubMed

57.

Hotta K, Kuwajima M, Ono A, et al. Disordered expression of glycolytic and gluconeogenic liver enzymes of juvenile visceral steatosis mice with systemic carnitine deficiency. Diabetes Res Clin Pract 1996; 32: 117–23PubMedCrossRef

58.

Hanson RW, Reshef L. Glyceroneogenesis revisited. Biochimie 2003; 85: 1199–205PubMedCrossRef

59.

Kalhan SC, Mahajan S, Burkett E, et al. Glyceroneogenesis and the source of glycerol for hepatic triacylglycerol synthesis in humans. J Biol Chem 2001; 276: 12928–31PubMedCrossRef

60.

Schofield PS, Kirk CJ, Sugden MC. Hormonal regulation of fat esterification & oxidation in hepatocytes from fed rats: modulation by 3-mercaptopicolinate. Biochem Int 1985; 10: 695–704PubMed

61.

Sun Y, Liu S, Ferguson S, et al. Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem 2002; 277: 23301–7PubMedCrossRef

62.

Vincent MF, Bontemps F, Van den Berghe G. Inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside in isolated rat hepatocytes. Biochem J 1992; 281 (Pt 1): 267–72PubMed

63.

Velasco G, Geelen MJ, Guzman M. Control of hepatic fatty acid oxidation by 5’-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. Arch Biochem Biophys 1997; 337: 169–75PubMedCrossRef

64.

Muoio DM, Seefeld K, Witters LA, et al. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 1999; 338 (Pt 3): 783–91PubMedCrossRef

65.

Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 1999; 277: E1–10PubMed

66.

Iglesias MA, Ye JM, Frangioudakis G, et al. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 2002; 51: 2886–94PubMedCrossRef

67.

Koyama Y, Galassetti P, Coker RH, et al. Prior exercise and the response to insulin-induced hypoglycemia in the dog. Am J Physiol Endocrinol Metab 2002; 282: E1128–38PubMed

68.

Pencek RR, James F, Lacy DB, et al. Interaction of insulin and prior exercise in control of hepatic metabolism of a glucose load. Diabetes 2003; 52: 1897–903PubMedCrossRef

69.

Devlin JT, Hirshman M, Horton ED, et al. Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise. Diabetes 1987; 36: 434–9PubMedCrossRef

70.

Devlin JT, Horton ES. Effects of prior high-intensity exercise on glucose metabolism in normal and insulin-resistant men. Diabetes 1985; 34: 973–9PubMedCrossRef

71.

Ryysy L, Hakkinen AM, Goto T, et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000; 49: 749–58PubMedCrossRef

72.

Ueno T, Sugawara H, Sujaku K, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997; 27: 103–7PubMedCrossRef

73.

Borsheim E, Knardahl S, Hostmark AT. Short-term effects of exercise on plasma very low density lipoproteins (VLDL) and fatty acids. Med Sci Sports Exerc 1999; 31: 522–30PubMedCrossRef

74.

Barakat HA, Kasperek GJ, Dohm GL, et al. Fatty acid oxidation by liver and muscle preparations of exhaustively exercised rats. Biochem J 1982; 208: 419–24PubMed

75.

Gorski J, Nowacka M, Namiot Z, et al. Effect of prolonged exercise on the level of triglycerides in the rat liver. Eur J Appl Physiol Occup Physiol 1988; 57: 554–7PubMedCrossRef

76.

Gorski J, Kiryluk T. The post-exercise recovery of triglycerides in rat tissues. Eur J Appl Physiol Occup Physiol 1980; 45: 33–41PubMedCrossRef

77.

Itani SI, Ruderman NB, Schmieder F, et al. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002; 51: 2005–11PubMedCrossRef

78.

Dohm GL, Newsholme EA. Metabolic control of hepatic gluconeogenesis during exercise. Biochem J 1983; 212: 633–9PubMed

79.

Sanchez-Medina F, Sanchez-Urrutia L, Medina JM, et al. Effect of muscular exercise and glycogen depletion on rat liver and kidney phosphoenolpyruvate carboxykinase. FEBS Lett 1971; 19: 128–30PubMedCrossRef

80.

Satabin P, Bois-Joyeux B, Chanez M, et al. Effects of long-term feeding of highprotein or high-fat diets on the response to exercise in the rat. Eur J Appl Physiol Occup Physiol 1989; 58: 583–90PubMedCrossRef

81.

Friedman JE. Role of glucocorticoids in activation of hepatic PEPCK gene transcription during exercise. Am J Physiol 1994; 266: E560–6PubMed

82.

Carlson CL, Winder WW. Liver AMP-activated protein kinase and acetyl-CoA carboxylase during and after exercise. J Appl Physiol 1999; 86: 669–74PubMed

83.

Guzman M, Castro J. Effects of endurance exercise on carnitine palmitoyltransferase I from rat heart, skeletal muscle and liver mitochondria. Biochim Biophys Acta 1988; 963: 562–5PubMedCrossRef

84.

Fiebig RG, Hollander JM, Ji LL. Exercise down-regulates hepatic fatty acid synthase in streptozotocin-treated rats. J Nutr 2001; 131: 2252–9PubMed

85.

Winder WW, Booth FW, Fitts RH, et al. Effect of exercise on response of liver lipogenic enzymes to a high fructose diet. Proc Soc Exp Biol Med 1975; 148: 1150–4PubMed

86.

Foretz M, Carling D, Guichard C, et al. AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes. J Biol Chem 1998; 273: 14767–71PubMedCrossRef

87.

Bogardus C, Ravussin E, Robbins DC, et al. Effects of physical training and diet therapy on carbohydrate metabolism in patients with glucose intolerance and non-insulin-dependent diabetes mellitus. Diabetes 1984; 33: 311–8PubMedCrossRef

88.

Gorski J, Oscai LB, Palmer WK. Hepatic lipid metabolism in exercise and training. Med Sci Sports Exerc 1990; 22: 213–21PubMed

89.

Despres JP, Tremblay A, Nadeau A, et al. Physical training and changes in regional adipose tissue distribution. Acta Med Scand Suppl 1988; 723: 205–12PubMed

90.

Shimomura I, Tokunaga K, Kotani K, et al. Marked reduction of acyl-CoA synthetase activity and mRNA in intra-abdominal visceral fat by physical exercise. Am J Physiol 1993; 265: E44–50PubMed

91.

Fukuda N, Tojho M, Hidaka T, et al. Reciprocal responses to exercise in hepatic ketogenesis and lipid secretion in the rat. Ann Nutr Metab 1991; 35: 233–41PubMedCrossRef

92.

Podolin DA, Pagliassotti MJ, Gleeson TT, et al. Influence of endurance training on the age-related decline in hepatic glyconeogenesis. Mech Ageing Dev 1994; 75: 81–93PubMedCrossRef

93.

Zawalich W, Maturo S, Felig P. Influence of physical training on insulin release and glucose utilization by islet cells and liver glucokinase activity in the rat. Am J Physiol 1982; 243: E464–9PubMed

94.

Sakamoto K, Goodyear LJ. Invited review: intracellular signaling in contracting skeletal muscle. J Appl Physiol 2002; 93: 369–83PubMed

95.

Kirwan JP, Jing M. Modulation of insulin signaling in human skeletal muscle in response to exercise. Exerc Sport Sci Rev 2002; 30: 85–90PubMedCrossRef

96.

Cusi K, Maezono K, Osman A, et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000; 105: 311–20PubMedCrossRef

97.

Kirwan JP, del Aguila LF, Hernandez JM, et al. Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletal muscle. J Appl Physiol 2000; 88: 797–803PubMed

98.

Houmard JA, Shaw CD, Hickey MS, et al. Effect of short-term exercise training on insulin-stimulated PI 3-kinase activity in human skeletal muscle. Am J Physiol 1999; 277: E1055–60PubMed

99.

Bonen A, Clune PA, Tan MH. Chronic exercise increases insulin binding in muscles but not liver. Am J Physiol 1986; 251: E196–203PubMed

Title: Lipid-Induced Insulin Resistance in the Liver
Role of Exercise
Author: Dr Christos S. Katsanos
Publication date: 01-12-2004
Publisher: Springer International Publishing
Published in: Sports Medicine / Issue 14/2004
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI: https://doi.org/10.2165/00007256-200434140-00002

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Lipid-Induced Insulin Resistance in the Liver

Role of Exercise

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 14/2004

Exercise Programmes for Patients with Chronic Heart Failure

Optimising Exercise Training in Peripheral Arterial Disease

Does Overtraining Exist?

Biomechanics and Pathophysiology of Overuse Tendon Injuries